Here’s a quick look at stocks likely to be in focus in today's trade. Tata Steel: Tata Steel Ltd announced that the Neath ...
Shares of firms like Vedanta, Tata Steel, RVNL, Max Healthcare, Allcargo Gati, and others will be in focus on Wednesday's ...
With healthcare rapidly evolving through digital transformation, the demand for smarter, more efficient solutions is rising, ...
5h
Investor's Business Daily on MSNWhy Medtronic Just Undercut Its Buy Zone With A 7% DropMedtronic stock skidded Tuesday after the medtech giant missed sales expectations, though profit came in well ahead of forecasts.
Stocks like Indian Overseas Bank, Larsen & Toubro, Container Corporation of India, Cello World, RBM Infracon, Bharti Airtel, Voler Car, PS Raj Steels, and Maxvolt Energy Industries will be in focus on ...
Ever heard of the “January effect?” In case you haven’t, a “January effect” is considered a phenomenon in the stock market ...
Ever heard of the “January effect?” In case you haven’t, a “January effect” is considered a phenomenon in the stock market ...
7h
Stockhead on MSNMiddle East healthcare expansion opens doors for ASX stocksThe Middle East healthcare sector is undergoing rapid expansion presenting opportunities for ASX-listed companies. ... Read ...
Deutsche Bank upgraded Gilead Sciences (NASDAQ:GILD) on Tuesday, citing the antiviral developer’s HIV treatment franchise, and downgraded Merck (NYSE:MRK), citing the cancer drugmaker’s upcoming loss ...
The trial data, which was reported on February 18, 2025, also suggested potential cardiac benefits from the therapy. The company mentioned that SGT-003 has been well-tolerated with no serious adverse ...
D Molecular Therapeutics is undervalued, with its lead candidate 4D-150 showing potential. Click here to find out why I rate FDMT stock a Buy.
EPS estimates but beats revenue expectations. Barclays downgrades stock, citing COVID demand decline and RSV uptake ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results